Arjo AB (publ) - Asset Resilience Ratio
Arjo AB (publ) (ARJO-B) has an Asset Resilience Ratio of 0.18% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ARJO-B liabilities breakdown for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2013–2023)
This chart shows how Arjo AB (publ)'s Asset Resilience Ratio has changed over time. See shareholders equity of Arjo AB (publ) for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Arjo AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Arjo AB (publ) (ARJO-B) total market value.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr28.00 Million | 0.18% |
| Total Liquid Assets | Skr28.00 Million | 0.18% |
Asset Resilience Insights
- Limited Liquidity: Arjo AB (publ) maintains only 0.18% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Arjo AB (publ) Industry Peers by Asset Resilience Ratio
Compare Arjo AB (publ)'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.44% |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332 |
Medical Distribution | 5.56% |
Annual Asset Resilience Ratio for Arjo AB (publ) (2013–2023)
The table below shows the annual Asset Resilience Ratio data for Arjo AB (publ).
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.47% | Skr76.00 Million ≈ $8.18 Million |
Skr16.00 Billion ≈ $1.72 Billion |
-3.73pp |
| 2022-12-31 | 4.20% | Skr679.00 Million ≈ $73.07 Million |
Skr16.17 Billion ≈ $1.74 Billion |
+1.00pp |
| 2021-12-31 | 3.20% | Skr468.00 Million ≈ $50.36 Million |
Skr14.61 Billion ≈ $1.57 Billion |
-3.41pp |
| 2020-12-31 | 6.62% | Skr917.00 Million ≈ $98.68 Million |
Skr13.86 Billion ≈ $1.49 Billion |
+2.35pp |
| 2019-12-31 | 4.27% | Skr616.00 Million ≈ $66.29 Million |
Skr14.42 Billion ≈ $1.55 Billion |
-3.16pp |
| 2018-12-31 | 7.43% | Skr976.00 Million ≈ $105.03 Million |
Skr13.14 Billion ≈ $1.41 Billion |
+1.64pp |
| 2017-12-31 | 5.79% | Skr707.00 Million ≈ $76.08 Million |
Skr12.21 Billion ≈ $1.31 Billion |
-4.83pp |
| 2016-12-31 | 10.62% | Skr1.56 Billion ≈ $168.10 Million |
Skr14.71 Billion ≈ $1.58 Billion |
+10.22pp |
| 2015-12-31 | 0.39% | Skr55.00 Million ≈ $5.92 Million |
Skr14.02 Billion ≈ $1.51 Billion |
+0.07pp |
| 2014-12-31 | 0.32% | Skr48.00 Million ≈ $5.17 Million |
Skr14.82 Billion ≈ $1.60 Billion |
-0.29pp |
| 2013-12-31 | 0.61% | Skr81.00 Million ≈ $8.72 Million |
Skr13.22 Billion ≈ $1.42 Billion |
-- |
About Arjo AB (publ)
Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia, Latin America, Africa, and Pacific. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and pr… Read more